Actively Recruiting
Neuropathic Characteristics of Subacromial Pain Syndrome
Led by Izmir City Hospital · Updated on 2026-04-14
82
Participants Needed
1
Research Sites
37 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This single-center observational study aims to investigate neuropathic pain descriptors and their relationship with central sensitization in patients diagnosed with subacromial pain syndrome (SAPS) who have had shoulder pain for at least 3 months. A total of 82 participants aged 19 years or older will be recruited from the Physical Medicine and Rehabilitation outpatient clinic of Izmir City Hospital. After obtaining informed consent, participants will complete validated questionnaires assessing pain severity (VAS), neuropathic pain characteristics (painDETECT), central sensitization (Central Sensitization Inventory), and shoulder function (SPADI). Range of motion will be measured using a goniometer. No imaging or invasive procedures will be performed. Using the central sensitization scale and pain detect, the presence or absence of the 7 pain descriptors will be investigated in patients with subacromial pain syndrome with or without central sensitization and neuropathic pain pattern and it will be investigated whether the contribution of hyperalgesia, one of these pain descriptors, to neuropathic pain and central sensitization in patients with subacromial pain syndrome is greater than the contribution of other pain descriptors.The results of this study are expected to provide insight into pain mechanisms and guide clinical management in patients with SAPS.
CONDITIONS
Official Title
Neuropathic Characteristics of Subacromial Pain Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of subacromial pain syndrome (SAPS)
- Age 19 years or older
- Shoulder pain lasting for at least 3 months
- Shoulder pain intensity rated 3 or higher on the Visual Analog Scale (VAS) in the past week
- Positive results on clinical tests: Hawkins-Kennedy test, Painful arc test, Infraspinatus muscle strength test
You will not qualify if you...
- History of inflammatory disease involving the shoulder joint
- History of neurological disorders
- History of prior shoulder surgery
- Positive drop arm test
- Loss of passive range of motion in the shoulder joint
- Presence of muscle strength loss
- Structurally confirmed shoulder pathology based on imaging studies
- Full-thickness tear of the rotator cuff muscles
- Presence of neurodeficit in the upper extremity
- Diagnosis of cancer or active infection
- Use of medications for neuropathic pain within the past 3 months for any reason
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
İzmir City Hospital
Izmir, İzmir, Turkey (Türkiye), 35300
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here